Search Results

Showing results 7281 - 7290 for benefits

Progress in Neuroscience seminar (PINS) | Research | Weill Cornell Medicine

...OSRA)Toggle Office of Sponsored Research Administration (OSRA) menu options Indirect Costs & Fringe Benefit...

https://research.weill.cornell.edu/about-us/news-updates/progress-neuroscience-seminar-pins-44

Emerging Leaders in Neuroscience Seminar | Research | Weill Cornell Medicine

...OSRA)Toggle Office of Sponsored Research Administration (OSRA) menu options Indirect Costs & Fringe Benefit...

https://research.weill.cornell.edu/about-us/news-updates/emerging-leaders-neuroscience-seminar-3

Work in Progress Seminar | Research | Weill Cornell Medicine

...OSRA)Toggle Office of Sponsored Research Administration (OSRA) menu options Indirect Costs & Fringe Benefit...

https://research.weill.cornell.edu/about-us/news-updates/work-progress-seminar-6

A Longitudinal, Observational Study of Previously Treated Hemophilia Patients (PTPs) Switching Coagulation Replacement Factor Products | Comprehensive Hemophilia Treatment Center

...Hemophilia Historical Information Team Directory Patient CareToggle menu options For Patients For Providers Benefits...

https://hemophilia.weill.cornell.edu/clinical-trials/longitudinal-observational-study-previously-treated-hemophilia-patients-ptps

Phase 3, prospective, multi-center, open label study to investigate safety, immunogenicity, and hemostatic efficacy of PEGylated Factor VIII (BAX 855) in previously untreated patients (PUPs) < 6 years with severe hemophilia A (FVIII < 1%) | Comprehensive Hemophilia Treatment Center

...Hemophilia Historical Information Team Directory Patient CareToggle menu options For Patients For Providers Benefits...

https://hemophilia.weill.cornell.edu/clinical-trials/phase-3-prospective-multi-center-open-label-study-investigate-safety-immunogenicity

A Randomized, Multi-Center, Open-Label, Phase III Clinical Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of Prophylactic Emicizumab versus No Prophylaxis in Hemophilia A Patients with Inhibitors | Comprehensive Hemophilia Treatment Center

...Hemophilia Historical Information Team Directory Patient CareToggle menu options For Patients For Providers Benefits...

https://hemophilia.weill.cornell.edu/clinical-trials/randomized-multi-center-open-label-phase-iii-clinical-trial-evaluate-efficacy-safety

Cardiovascular Disease Symptoms Surprisingly High in Young Refugees | Research | Weill Cornell Medicine

...OSRA)Toggle Office of Sponsored Research Administration (OSRA) menu options Indirect Costs & Fringe Benefit...

https://research.weill.cornell.edu/about-us/news-updates/cardiovascular-disease-symptoms-surprisingly-high-young-refugees

Can Processed Electroencephalographic Indices Be Used to Estimate Postoperative Delirium Risk? | Department of Anesthesiology

...of 2012 Class of 2013 Class of 2014 Class of 2015 Class of 2016 Class of 2017 Class of 2018 Benefits...

https://anesthesiology.weill.cornell.edu/publications/can-processed-electroencephalographic-indices-be-used-to-estimate-postoperative

Cognitive impairment predicts engagement in inpatient stroke

...Cognitively impaired patients undergoing rehabilitation may benefit from modifications and interventions...

https://cbic.weill.cornell.edu/publications/cognitive-impairment-predicts-engagement-inpatient-stroke-rehabilitation

Adults with Cerebral Palsy: Navigating the Complexities of Aging

...professionals' lack of expertise present significant obstacles to achieving quality healthcare and long-term benefits...

https://cbic.weill.cornell.edu/publications/adults-cerebral-palsy-navigating-complexities-aging

Showing results 7281 - 7290 for benefits